New Market Report Now Available: Switzerland Pharmaceuticals & Healthcare Report Q2 2014
Most of Switzerland's demographic and economic indicators are favourable towards increased pharmaceutical and healthcare spending. The pensionable population proportion is high and growing, and this will translate into greater demand for drugs. Furthermore, the country's highly developed infrastructure means that access to healthcare is easy, further supporting the consumption of medicines.
View full press release